Stay informed with the latest updates for the inheritable blood disorders community. NHF & Community NHF Applauds Implementation of the Hemophilia SNF Access Act Oct 1, 2021 Medical Prophylaxis Indication Restored for BeneFIX® Sep 14, 2021 Industry Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011 Aug 2, 2021 Industry FDA Places Clinical Hold on Sigilon’s Investigational Hemophilia Therapy Jul 12, 2021 Industry BioMarin Presents Positive Safety and Efficacy Data for their… May 27, 2021 Industry Gene Therapy Trial Data Suggests Efficacy in the Presence of Antibodies May 25, 2021 Industry Gene Therapy Licensing Agreement Between uniQure and CSL Now in Effect May 7, 2021 Industry uniQure Announces End of Clinical Hold on Hemophilia B Gene Therapy… Apr 27, 2021 Industry uniQure Announces Findings from HCC Case Investigation Mar 30, 2021 Industry Update to Hemlibra® (emicizumab-kxwh) USPI Mar 12, 2021 Industry New Program Looks to Standardize Care for Patients with Rare Diseases Mar 2, 2021 Industry FDA Partially Rescinds Added Indications for Two FIX Products Feb 23, 2021 Industry Sanofi Revises Fitusiran Dosing Regimen to Mitigate Risk of Vascular… Feb 22, 2021 Industry Spark Announces Preliminary Data from Investigational Gene Therapy Trial Feb 19, 2021 Industry Octapharma Announces Final Results of Nuwiq® Study Feb 19, 2021 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page
